Atlas Trials

Pharmacokinetics, Pharmacodynamics And Safety Study Of Elelyso(tm) In Pediatric Subjects With Type 1 Gaucher Disease

Clinical trial NCT03021941 · WITHDRAWN

Trial details

NCT number
NCT03021941
Sponsor
Pfizer
Status
WITHDRAWN
Phase
Phase 4
Study type
INTERVENTIONAL
Type 1 Gaucher Disease
Start date
2019-07-31
Primary completion
2020-06-30
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.